The patentability of antibodies in the United States.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16151395.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent US case law attempts to further clarify the written description, novelty and non-obviousness requirements as they apply to antibodies
Medical subject headings
- Antibodies
- Biotechnology
- Drug Industry
- Patents as Topic